Kevin S. Gould, SVP Clinical Controls at BIO-TECHNE Corp (TECH), sold 524 shares at $110.50 ($58K) on 2016-09-08, disclosed to the SEC on 2016-09-12.
Open-market sale of $58k TECH by SVP Clinical Controls. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.